Jeffrey Lorne Kadanoff Insider Profile
4 Followers
Jeffrey Lorne Kadanoff, Chief Financial Officer at Knight Therapeutics, holds 86.67K shares in Carebook Technologies Inc (Ticker: TSE:CRBK), holds 168.72K shares in Knight Therapeutics (Ticker: KHTRF). Most recently, Jeffrey Lorne Kadanoff Bought ― shares of Carebook Technologies Inc on May 20, 2022 for an estimated value of C$10.00K.
Jeffrey Lorne Kadanoff's Trading History
| CRBKCarebook Technologies Inc | May 20, 2022 | ― | Informative Buy | 10.00K | C$8.23K | |
| KHTRFKnight Therapeutics | Sep 20, 2017 | Chief Financial Officer | Uninformative Buy | 7.09K | $1.41M |
You May Also Like
Jeffrey Lorne Kadanoff insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Lorne Kadanoff?
The percentage of profitable transactions made by Jeffrey Lorne Kadanoff is 33%.
What is the average return per transaction made by Jeffrey Lorne Kadanoff?
The average return per transaction made by Jeffrey Lorne Kadanoff is -19.90%.
What stocks does Jeffrey Lorne Kadanoff hold?
Jeffrey Lorne Kadanoff holds: KHTRF, TSE:CRBK stocks.
What was Jeffrey Lorne Kadanoff’s latest transaction?
Jeffrey Lorne Kadanoff’s latest transaction was an Informative Buy of C$10.00K.
What was Jeffrey Lorne Kadanoff's most profitable transaction?
Jeffrey Lorne Kadanoff’s most profitable transaction was an Informative Buy of KHTRF stock on June 6, 2016. The return on the trade was 10.20%.
What is Jeffrey Lorne Kadanoff's role in Knight Therapeutics?
Jeffrey Lorne Kadanoff's role in Knight Therapeutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
